Keywords: SNC، substantia nigra pars compact; DA, dopaminergic; DBS, deep brain stimulation; GPe, external globus pallidus; GPi, internal globus pallidus; PD, Parkinson’s disease; PPN, pedunculopontine; SNc, substantia nigra pars compacta; SNr, substantia nigra pars reticulata; STN, subthalamic nucle
مقالات ISI SNC، substantia nigra pars compact (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: SNC، substantia nigra pars compact; MTA, mitochondria-targeted antioxidant; PD, Parkinson's disease; SNc, substantia nigra pars compacta; ETC, electron transport chains; O2−, superoxide anion; ROS, reactive oxygen species; NO, nitric oxide; TCA, tricarboxylic acid cycle; ONOO−, peroxynitrit
Indirect application of near infrared light induces neuroprotection in a mouse model of parkinsonism – An abscopal neuroprotective effect
Keywords: SNC، substantia nigra pars compact; GFAP, glial fibrillary acidic protein; IBA1, ionized calcium-binding adapter molecule 1; LED, light-emitting device; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NIr, near infrared light; PBM, photobiomodulation; SNc, substantia nigra pars compacta
Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): A preliminary cross-sectional study of 20 Parkinson’s disease patients
Keywords: SNC، substantia nigra pars compact; ESWAN, enhanced T2 star weighted angiography; MRI, magnetic resonance imaging; MPV, mean phase value; PD, Parkinson's disease; SN, substantia nigra; SNr, substantia nigra pars reticulate; SNc, substantia nigra pars compacta; RN, red nucleusIron deposition
Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis
Keywords: SNC، substantia nigra pars compact; PD, Parkinson's disease; MRI, Magnetic resonance imaging; DTI, Diffusion tensor imaging; MD, Mean diffusivity; ADC, Apparent diffusion coefficient; SN, Substantia nigra; SNc, Substantia nigra pars compacta; DES, Effect size of disease related nigral chang
Amelioration of rotenone-induced dopaminergic cell death in the striatum by oxytocin treatment
Keywords: SNC، substantia nigra pars compact; OT, oxytocin; PD, Parkinson's disease; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; OTR, oxytocin receptors; DMSO, dimethyl sulfoxide; SNc, substantia nigra pars compacta; VTA, ventral tegmental area; TH, tyrosine hydroxylase; Bcl-2, B-cell lymphom
Impaired hepatic function and central dopaminergic denervation in a rodent model of Parkinson's disease: A self-perpetuating crosstalk?
Keywords: SNC، substantia nigra pars compact; PD, Parkinson's disease; 6-OHDA, 6-hydroxydopamine; CSF, cerebrospinal fluid; ROS, reactive oxygen species; ΔΨ, mitochondrial membrane potential; SNc, substantia nigra pars compacta; TH, Tyrosine Hydroxylase; DA, dopamine; DAT, dopamine transporter; ATP,
Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease
Keywords: SNC، substantia nigra pars compact; MAO-B, monoamine oxidase-B; PPAR, peroxisome proliferator-activated receptor; SNc, substantia nigra pars compacta; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 6-OHDA, 6-hydroxydopamine; VTA, ventral tegmental area; TH, tyrosine hydroxylasePPAR; Pi
Full and partial peroxisome proliferation-activated receptor-gamma agonists, but not delta agonist, rescue of dopaminergic neurons in the 6-OHDA Parkinsonian model is associated with inhibition of microglial activation and MMP expression
Keywords: SNC، substantia nigra pars compact; HPLC-ECD, High performance liquid chromatography-Electrochemical detection; 6-OHDA, 6-hydroxydopamine; mfb, medial forebrain bundle; PD, Parkinson's disease; SNc, substantia nigra pars compacta; PPAR, Peroxisome proliferator-activated receptor; MMP, matri
Coupled intracerebral microdialysis and electrophysiology for the assessment of dopamine neuron function in vivo
Keywords: SNC، substantia nigra pars compact; DA, dopamine; DOPAC, 3,4-dihydroxyphenylacetic acid; NAc, nucleus accumbens; SNc, substantia nigra pars compacta; VTA, ventral tegmental area; PLSD, protected least significance differenceDopamine; In vivo electrophysiology; In vivo microdialysis; Mouse;
A new alternative NF-ΚB Pathway mediated the neuroprotection of GDNF on 6-OHDA-induced DA neurons neurotoxicity
Keywords: SNC، substantia nigra pars compact; GDNF, glial cell line-derived neurotrophic factor; DA, dopaminergic; SNc, substantia nigra pars compacta; NIK, NF-κB-inducing kinase; I B, inhibitor of B; IKK, I B kinase; TH, tyrosine hydroxylaseGDNF; DA neurons; NIK; IKKα; NF-κB
Exercise exerts neuroprotective effects on Parkinson's disease model of rats
Keywords: SNC، substantia nigra pars compact; BDNF, brain-derived neurotrophic factor; BrdU, 5-bromo-2′-deoxy-uridine; DA, dopamine; Dcx, doublecortin; GDNF, glial cell line-derived neurotrophic factor; HPF, high-power field; PD, Parkinson's disease; SNc, substantia nigra pars compacta; SVZ, subventr
Dopamine agonists increase perseverative instrumental responses but do not restore habit formation in a rat model of Parkinsonism
Keywords: SNC، substantia nigra pars compact; habit; instrumental learning; striatum; dopamine; D1 and D2 receptors; compulsive behaviorA–O, action–outcome association; DA, dopamine; SNc, substantia nigra pars compacta; S–R, Stimulus–Response; 6-OHDA, 6-hydroxydopamine
Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson's disease
Keywords: SNC، substantia nigra pars compact; PD, Parkinson's disease; DA, dopaminergic; SNc, substantia nigra pars compacta; NMDA, N-methyl-d-aspartate; DNQX, 6,7-dinitroquinoxaline-2,3(1H,4H)-dione; MAPK, mitogen-activated protein kinase; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; JNK, c-J
Intrapallidal injection of 6-hydroxydopamine induced changes in dopamine innervation and neuronal activity of globus pallidus
Keywords: SNC، substantia nigra pars compact; Parkinson's disease; globus pallidus; basal ganglia; dopamine; 6-hydroxydopamine; extracellular recordingGP, globus pallidus; GPe, external part of globus pallidus; PBS, phosphate-buffered saline; SNc, substantia nigra pars compacta; SNr, substantia nigra
Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide
Keywords: SNC، substantia nigra pars compact; LPS, lipopolysaccharide; CNS, central nerve system; E. coli, Escherichia coli; UTI, urinary tract infections; DA, dopamine; SN, substantia nigra; SNc, substantia nigra pars compacta; SNr, substantia nigra pars reticulate; PD, Parkinson's disease; 5-HT, se
Sumoylation is critical for DJ-1 to repress p53 transcriptional activity
Keywords: SNC، substantia nigra pars compact; PD, Parkinson’s disease; SNc, substantia nigra pars compacta; Bax, Bcl-2 associated X protein; EGFP, enhanced green fluorescent protein; PBS, phosphate buffer solution; DMEM, Dulbecco’s modified Eagle’s medium; Erk1, extracellular signal-regulated kinases
The firing activity of presumed cholinergic and non-cholinergic neurons of the pedunculopontine nucleus in 6-hydroxydopamine-lesioned rats: An in vivo electrophysiological study
Keywords: SNC، substantia nigra pars compact; DRN, dorsal raphe nucleus; EP, entopeduncular nucleus; 6-OHDA, 6-hydroxydopamine; ISIH, interspike interval histogram; LDT, laterodorsal tegmental nucleus; PD, Parkinson's disease; PPN, pedunculopontine nucleus; SNc, substantia nigra pars compacta; SNr, s
Selective loss of nigral dopamine neurons induced by overexpression of truncated human α-synuclein in mice
Keywords: SNC، substantia nigra pars compact; DA, dopamine; H&E, hematoxylin and eosin; LB, Lewy body; PD, Parkinson's disease; SNc, substantia nigra pars compacta; Tg, transgenic; TH, tyrosine hydroxylase; VTA, ventral tegmental areaParkinson's disease; Animal model; α-Synuclein; Transgenic mouse; T
Fluoro-Jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methy-4-phenyl-1,2,3,6-tetrahydro pyrindine-treated C57BL/6 mice
Keywords: SNC، substantia nigra pars compact; FJC, Fluoro-Jade C; GFAP, glial fibrillary acid protein; MPTP, 1-methy-4-phenyl-1,2,3,6-tetrahydro pyrindine; NeuN, neuron-specific nuclear protein or neuronal nuclei; SNc, substantia nigra pars compacta; TH, tyrosine hydroxylase; PD, Parkinson's diseaseF
Generation and survival of midbrain dopaminergic neurons in weaver mice
Keywords: SNC، substantia nigra pars compact; [3H]TdR, tritiated thymidine; SNc, substantia nigra pars compacta; TH, tyrosine hydroxylase; VTA, ventral tegmental areaWeaver mice; Midbrain; Dopaminergic neurons; Neurogenesis; Autoradiography; Immunocytochemistry
Identification of forkhead transcription factors in cortical and dopaminergic areas of the adult murine brain
Keywords: SNC، substantia nigra pars compact; Development and regeneration, Developmental geneticsILF1, interleukin enhancer binding factor 1; mDA, midbrain dopamine; SNc, substantia nigra pars compacta; VTA, ventral tegmental areaForkhead; Transcription factor; Expression; Dopamine; Brain; Developme
A neural network model of Parkinson's disease bradykinesia
Keywords: SNC، substantia nigra pars compact; Bradykinesia; Parkinson's disease; Dopamine; Cortex; Spinal cord; Basal ganglia; Reaction time; Movement timeDA, dopamine; MPTP, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine; SNc, substantia nigra pars compacta; GPe, external segment of globus pallidus; G